Skip to Main Content

Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET.

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT cancer reporter Angus Chen will be joined by Olivia Goldhill, investigative reporter here at STAT. They will be discussing Olivia’s recent report exploring how these long-stigmatized psychedelic drugs are advancing, the opportunities for growth and potential barriers in the industry, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment